NCT05585931View on ClinicalTrials.gov

Effect of TPN171H on Spermatogenesis

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 15, 2022

Primary Completion Date

December 16, 2022

Study Completion Date

December 16, 2022

Conditions
Erectile Dysfunction
Interventions
DRUG

TPN171H 10mg

Subjects were given 10mg TPN171H tablet with 240 mL warm water under fasting condition.

DRUG

TPN171H Placebo

Subjects were given Placebo with 240 mL warm water under fasting condition.

Trial Locations (1)

100032

Peking University First Hospital, Beijing

All Listed Sponsors
lead

Vigonvita Life Sciences

INDUSTRY